BLAUVELT, A. .; THACI, D.; PAPP, K.; HO, V. .; GHORESCHI, K.; KIM, B. S.; MILLER, M. .; SHEN, Y.-K. .; YOU, Y.; YU, J.; YANG, Y.-W.; CROWLEY, J.; FOLEY, P. Guselkumab (GUS) in Psoriasis Patients With a History of Malignancy: 5-Year Safety From VOYAGE (VOY)1&2 . SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 2, p. s2, 2022. DOI: 10.25251/skin.6.supp.2. Disponível em: Acesso em: 16 aug. 2022.